Mercaptor joined the movement in October 2017 and walked to defeat ALS. The ALS association unites with the community to raise funds for those living with ALS. The fundraising fuels bold and urgent innovation as we march together toward a cure for ALS. Mercaptor plans to join the march again in April 2018! https://secure2.convio.net/alsa/site/SPageServer?pagename=WLK_landing
Mercaptor’s CEO Sara Isbell is featured in South Bay Accent Magazine’s cover story, 25 Ways to Boost Mood! http://bit.ly/SBACover
Listen to Mercaptor Discoveries CEO Sara Isbell on “Locked on Broncos” with NFL Analyst Cody Roark. Cody Roark (@CodyRoarkNFL) 2/9/18, 3:13 PM PODCAST: February 9: Interview w/ Sara Isbell from Mercaptor Discoveries @Mercaptor1 Talking About Identifying CTE and the latest advances in Concussion knowledge. https://t.co/EGFDgHaAAw
Sara takes a few minutes with Rich from KCBS in Las Vegas to talk about what Mercaptor has been up to. Listen in:
We were recently featured in Sports Illustrated. View the full article here: https://www.si.com/nfl/2018/01/03/football-concussion-cte-players-mercaptor-captons-jim-kovach
By TOM TAYLOR January 03, 2018 The more science teaches us about head injury, the more football seems to be doomed. But could science also save football? Might medicine offer us a miracle cure for degenerative brain disease? Since 2008, pathologists at Boston University have been repeatedly raising the alarm about the effects of life […]
Ralph O’Rear provides Mercaptor strategic advice with regards to general business strategy, facilities, and operations. After 18 years at the Buck Institute for Research on Aging and nearly 10 years at Lucasfilm Ltd. and its subsidiaries and affiliates (Industrial Light and Magic, LucasArts Entertainment, THX), Mr. O’Rear began to independently consult with the goal of doing […]
Mercaptor is pursuing non-dilutive funding for preclinical studies in models of stroke, TBI, Seizers, amyotrophic lateral sclerosis, and stroke. Proof-of-concept data will gate additional fundraising efforts. Our goal is to bring drug candidates to the clinical stage in both humans and companion animals.
Sara Isbell has an extensive background in neuroscience, with specific training and expertise in neurodegenerative diseases and conditions, including a recently published paper in drug design and development in Dove Medical Press. Over the course of her 22-year career as she developed novel experiments and consistently contributed to cutting-edge research. This experience was integral to […]